THE SCIENTIFIC DISCOURSE OF MANIFESTATION ON KEY ISSUE ASPECTS OF FEATURES, ROLE AND FUNCTION OF THE FAMILY DOCTOR IN THE 21 CENTURY IN GENERAL
Downloads
The role of the family doctor, or general practitioner (GP), has been a cornerstone of healthcare systems globally for decades. However, the 21st century has ushered in an unprecedented convergence of demographic shifts, technological advancements, economic pressures, and evolving patient expectations that have fundamentally challenged and transformed this role. This extensive discussion delves into the scientific discourse surrounding the key features, roles, and functions of the contemporary family doctor. It moves beyond a simple description of tasks to explore the complex interplay between the core principles of primary care and the demands of modern medicine. The analysis is structured around several critical themes: the evolution from a generalist to a precisionist and navigator; the impact of digital health technologies, including AI and telemedicine; the imperative of person-centeredness and shared decision-making in an era of consumerism; the challenges posed by multimorbidity and an aging population; the family doctor as a leader and coordinator within integrated care systems; and the ongoing issues of workforce sustainability and professional identity. By synthesizing evidence from health services research, sociology, health policy, and clinical medicine, this discussion argues that the 21st-century family doctor must embody a paradoxical identity: both a high-tech diagnostician and a high-touch healer, a data-driven manager and an empathetic confidant, a system leader and a patient advocate. The future resilience of healthcare systems depends on recognizing, supporting, and strategically investing in this evolved and complex role.The first and most defining feature is that of a specialist in whole-person medicine. Eschewing a narrow organ- or disease-focused perspective, the family doctor employs a biopsychosocial model, understanding that illness is often an interplay of biological, psychological, and social factors. This holistic lens is the only effective approach for managing multimorbidity, viewing it not as a collection of discrete diseases but as a unified state affecting a single individual. The second cardinal feature is longitudinality, or continuity of care. The long-term relationship spanning generations and life stages is a powerful diagnostic and therapeutic tool in itself, fostering deep trust, enabling the detection of subtle changes over time, and providing the essential context for meaningful clinical decisions. The third feature is the function as the first point of contact and the navigator of the healthcare system. The family doctor acts as the primary entry point, performing initial assessment and triage, managing the majority of presenting problems, and coordinating specialist referrals when needed. This ensures the right patient sees the right specialist at the right time, enhancing efficiency and preventing care fragmentation. These core features give rise to a multifaceted and expanding set of roles and functions. The clinical role remains paramount but has evolved; diagnosis now often involves unraveling the complex interplay of multiple conditions, while management focuses on optimization of function, medication regimens, and quality of life aligned with patient goals. This requires mastery of therapeutic communication and motivational interviewing. Inextricably linked is the role of health promoter and preventive medicine expert. In an era of lifestyle-driven chronic diseases, the family doctor provides evidence-based counseling on risk factors and orchestrates screening programs, increasingly utilizing data-driven risk assessment tools. Perhaps the most critical emerging function is that of care coordinator and integrator. The family doctor sits at the center of a network of specialists and allied health professionals, reconciling treatments, synthesizing advice, and ensuring a coherent, safe, and manageable care plan, thus safeguarding against systemic fragmentation. Acting as a patient advocate is another crucial function, both at the individual level—navigating insurance and system bureaucracy on behalf of the patient—and at a community level, identifying and addressing public health concerns. The family doctor remains the essential human counterbalance to technological and systemic fragmentation, ensuring that advanced medicine retains its compassionate core and unwavering focus on the whole person throughout their life journey.
Downloads
Star field B. Is primary care essential? Lancet. 2014 Oct 22;344(8930):1129-33.
World Health Organization. Declaration of Alma-Ata. International Conference on Primary Health Care; 1978 Sep 6-12; Alma-Ata, USSR.
World Organization of Family Doctors (WONCA). The European Definition of General Practice / Family Medicine. WONCA Europe; 2011.
McWhinney IR. Why we need a new clinical method. In: Stewart M, Brown JB, Weston WW, McWhinney IR, McWilliam CL, Freeman TR, editors. Patient-centered medicine: transforming the clinical method. Abingdon: Radcliffe Medical Press; 1995. p. 1-19.
Heath I. The mystery of general practice. London: The Nuffield Trust; 1995.
Green LA, Fryer GE Jr, Yawn BP, Lanier D, Dovey SM. The ecology of medical care revisited. N Engl J Med. 2001 Jun 28;344(26):2021-5.
Stange KC. The generalist approach. Ann Fam Med. 2010 Jan-Feb;8(1):1-2.
Reeves S, Pelone F, Harrison R, Goldman J, Zwarenstein M. Interprofessional collaboration to improve professional practice and healthcare outcomes. Cochrane Database Syst Rev. 2017 Jun 22;6(6):CD000072.
Bodenheimer T, Sinsky C. From triple to quadruple aim: care of the patient requires care of the provider. Ann Fam Med. 2014 Nov-Dec;12(6):573-6.
Shanafelt TD, Boone S, Tan L, Dyrbye LN, Sotile W, Satele D, et al. Burnout and satisfaction with work-life balance among US physicians relative to the general US population. Arch Intern Med. 2012 Oct 8;172(18):1377-85.
Sinsky C, Colligan L, Li L, Prgomet M, Reynolds S, Goeders L, et al. Allocation of Physician Time in Ambulatory Practice: A Time and Motion Study in 4 Specialties. Ann Intern Med. 2016 Dec 6;165(11):753-60.
Østbye T, Yarnall KS, Krause KM, Pollak KI, Gradison M, Michener JL. Is there time for management of patients with chronic diseases in primary care? Ann Fam Med. 2005 May-Jun;3(3):209-14.
Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012 Jul 7;380(9836):37-43.
Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA. 2005 Aug 10;294(6):716-24.
Scott IA, Hilmer SN, Reeve E, Potter K, Le Couteur D, Rigby D, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015 May;175(5):827-34.
Wagner EH, Austin BT, Von Korff M. Organizing care for patients with chronic illness. Milbank Q. 1996;74(4):511-44.
Coleman K, Austin BT, Brach C, Wagner EH. Evidence on the Chronic Care Model in the new millennium. Health Aff (Millwood). 2009 Jan-Feb;28(1):75-85.
Barry MJ, Edgman-Levitan S. Shared decision making--pinnacle of patient-centered care. N Engl J Med. 2012 Mar 1;366(9):780-1.
Elwyn G, Frosch D, Thomson R, Joseph-Williams N, Lloyd A, Kinnersley P, et al. Shared decision making: a model for clinical practice. J Gen Intern Med. 2012 Oct;27(10):1361-7.
Mead N, Bower P. Patient-centredness: a conceptual framework and review of the empirical literature. Soc Sci Med. 2000 Oct;51(7):1087-110.
Emanuel EJ, Emanuel LL. Four models of the physician-patient relationship. JAMA. 1992 Apr 22-29;267(16):2221-6.
Topol EJ. Deep Medicine: How Artificial Intelligence Can Make Healthcare Human Again. New York: Basic Books; 2019.
Coiera E. Guide to Health Informatics. 3rd ed. Boca Raton: CRC Press; 2015.
Meyer AND, Giardina TD, Spitzmueller C, Shahid U, Scott TMT, Singh H. Patient perspectives on the usefulness of an artificial intelligence-assisted symptom checker: cross-sectional survey study. J Med Internet Res. 2020 Jan 30;22(1):e14679.
Monaghesh E, Hajizadeh A. The role of telehealth during COVID-19 outbreak: a systematic review based on current evidence. BMC Public Health. 2020 Aug 1;20(1):1193.
Doraiswamy S, Abraham A, Mamtani R, Cheema S. Use of Telehealth During the COVID-19 Pandemic: Scoping Review. J Med Internet Res. 2020 Dec 1;22(12):e24087.
Porter ME, Lee TH. The strategy that will fix health care. Harv Bus Rev. 2013 Oct;91(12):50-70.
Berwick DM, Nolan TW, Whittington J. The triple aim: care, health, and cost. Health Aff (Millwood). 2008 May-Jun;27(3):759-69.
Nutting PA, Crabtree BF, Miller WL, Stange KC, Stewart E, Jaén C. Transforming physician practices to patient-centered medical homes: lessons from the national demonstration project. Health Aff (Millwood). 2011 Mar;30(3):439-45.
Kringos DS, Boerma WGW, Hutchinson A, van der Zee J, Groenewegen PP. The breadth of primary care: a systematic literature review of its core dimensions. BMC Health Serv Res. 2010;10:65.
Ferrer RL, Hambidge SJ, Maly RC. The essential role of generalists in health care systems. Ann Intern Med. 2005 Oct 18;143(8):617-8.
Gawande A. Being Mortal: Medicine and What Matters in the End. New York: Metropolitan Books; 2014.
Murray SA, Kendall M, Mitchell G, Moine S, Amblàs-Novellas J, Boyd K. Palliative care from diagnosis to death. BMJ. 2017 Mar 8;356:j878.
Saultz JW. Defining and measuring interpersonal continuity of care. Ann Fam Med. 2003 Sep-Oct;1(3):134-43.
Haggerty JL, Reid RJ, Freeman GK, Starfield BH, Adair CE, McKendry R. Continuity of care: a multidisciplinary review. BMJ. 2003 Nov 22;327(7425):1219-21.
Zulman DM, Asch SM, Martins SB, Kerr EA, Hoffman BB, Goldstein MK. Quality of care for patients with multiple chronic conditions: the role of comorbidity interrelatedness. J Gen Intern Med. 2014 Mar;29(3):529-37.
Britten N, Stevenson FA, Barry CA, Barber N, Bradley CP. Misunderstandings in prescribing decisions in general practice: qualitative study. BMJ. 2000 Feb 19;320(7233):484-8.
Epstein RM, Street RL Jr. The values and value of patient-centered care. Ann Fam Med. 2011 Mar-Apr;9(2):100-3.
Christensen CM, Grossman JH, Hwang J. The Innovator's Prescription: A Disruptive Solution for Health Care. New York: McGraw-Hill; 2009.
Detsky AS, Gauthier SR, Fuchs VR. Specialization in medicine: how much is appropriate? JAMA. 2012 May 2;307(17):1851-2.
SULASHVILI, N., GORGASLIDZE, N., GABUNIA, L., RATIANI, L., KHETSURIANI, S., KRAVCHENKO, V., SULASHVILI, M. (2024). MANIFESTATION OF THE PARTICULARITIES OF SOME KEY ISSUE ASPECTS OF NEW IMMUNOTHERAPY CHALLENGES AND PERSPECTIVES BY CAR-T CELL THERAPY. Experimental and Clinical Medicine Georgia, (4), 119–121. https://doi.org/10.52340/jecm.2024.04.32.
SULASHVILI, N. . ., GORGASLIDZE , N. ., BEGLARYAN , M. ., GABUNIA , L. ., CHICHOYAN , N. ., GIORGOBIANI , M. ., … ZARNADZE, S. (DAVIT) . (2022). THE SCIENTIFIC TALKS OF ESSENTIAL ISSUE, INVOCATION, PERSPECTIVES, INCLINATIONS AND FEATURES OF THE CLINICAL PHARMACISTS GLOBALLY. Experimental and Clinical Medicine Georgia, (7).
Sulashvili N, Nimangre RR. MANIFESTATION OF SOME ASPECTS OF CARDIOVASCULAR DISEASES, IMPLICATIONS, PHARMACOTHERAPEUTIC STRATEGIES, EFFECTS, IMPACTS AND POTENTIAL HAZARDS IN GENERAL. JR [Internet]. 2025 Feb. 7 [cited 2025 May 22];3(1):1-27. Available from: https://journals.4science.ge/index.php/jr/article/view/3393.
Sulashvili N, Yaduvanshi U, Yadav M, Gabunia L, Ghambashidze K, Gorgaslidze N, et al. THE SCIENTIFIC DISCOURSE OF FEATURES OF CLINICAL USE AND PHARMACOLOGY OF VASOCONSTRICTORS AND THEIR IMPACT ON CARDIAC FUNCTION. JR [Internet]. 2025 Feb. 21 [cited 2025 May 22];3(1):28-6. Available from: https://journals.4science.ge/index.php/jr/article/view/3414.
Nodar Sulashvili, Nana Gorgaslidze, Margarita Beglaryan, Luiza Gabunia, Nato Alavidze, Nino Abuladze, Marina Giorgobiani, Marika Sulashvili, Tamar Okropiridze, and Lali Patsia. 2025. “THE SCIENTIFIC DISCOURSE OF KEY ISSUE ASPECTS OF FEATURES OF CANDIDA PROBLEMS, ANTIFUNGAL DRUGS RESISTANCE CONCERNS, MYCOTOXICOLOGY ISSUES, MYCOECOLOGY, BIOSAFETY RISKS AND EMERGING SOLUTIONS”. Modern Scientific Method, no. 9 (March). https://ojs.scipub.de/index.php/MSM/article/view/5423.
SULASHVILI, N., BEGLARYAN, M., GORGASLIDZE, N., KOCHARYAN, S., CHICHOYAN, N., GABUNIA, L., ZARNADZE, S. (DAVIT). (2023). THE DISCLOSURE OF FEATURES, CHARACTERISTICS, POSSIBILITIES AND SPECIALTIES OF CLINICAL PHARMACISTS AS MEDIATOR AMONG DOCTORS AND PATIENTS FOR ENHANCEMENT PUBLIC HEALTH SECTOR IN A GLOBAL WORLD. Experimental and Clinical Medicine Georgia, (4), 57–62. https://doi.org/10.52340/jecm.2023.04.15
Sulashvili N, Davitashvili M, Gorgaslidze N, Gabunia L, Beglaryan M, Alavidze N, et al. THE SCIENTIFIC DISCUSSION OF SOME ISSUES OF FEATURES AND CHALLENGES OF USING OF CAR-T CELLS IN IMMUNOTHERAPY. GS 2024 ;6(4):263-90.
Relling, Mary V., and William E. Evans. 2015. “Pharmacogenomics in the Clinic.” Nature 526 (7573): 343–50.
SULASHVILI N, GORGASLIDZE N, GABUNIA L, GIORGOBIANI M, RATIANI L. MANIFESTATION OF THE PARTICULARITIES OF THE USAGE FEATURES OF MONOCLONAL ANTIBODIES IN VARIOUS PHARMACOTHERAPEUTIC APPLICATIONS. jecmg [Internet]. 2023 Nov. 26 [cited 2025 Jul. 12];(4):52-7. Available from: https://journals.4science.ge/index.php/jecm/article/view/2413.
Sulashvili, Nodar, Irine Pkhakadze, Margarita Beglaryan, Ia Egnatievi, Manana Giorgobiani, Luiza Gabunia, Nana Gorgaslidze, Magda Davitashvili, Ada (Adel) Tadevosyan, and Lali Patsia. 2025. “THE SCIENTIFIC DISCUSSION OF KEY ISSUE ASPECTS OF MODERN ADVANCING INNOVATION OF LEARNING AND TEACHING METHODS AND PEDAGOGICAL APPROACHES IN HIGHER EDUCATION INSTITUTIONS IN MEDICAL EDUCATIONAL STUDY PROGRAMS DIRECTIONS GLOBALLY IN GENERAL”. Scientific Journal „Spectri“ 10 (2). https://doi.org/10.52340/spectri.2024.10.01.12.
GORGASLIDZE, NANA, NODAR SULASHVILI, LUIZA GABUNIA, LEVAN RATIANI, and MARINA GIORGOBIANI. 2023. “THE SINGULARITIES OF TEMOZOLOMIDE PHARMACOTHERAPEUTIC EFFECTS IN BRAIN TUMOR THERAPEUTIC APPLICATIONS”. Experimental and Clinical Medicine Georgia, no. 4 (November):62-66. https://doi.org/10.52340/jecm.2023.04.16.
SULASHVILI, NODAR, MARGARITA BEGLARYAN, NANA GORGASLIDZE, SEYRAN KOCHARYAN, NAIRA CHICHOYAN, LUIZA GABUNIA, IRINE ZARNADZE, et al. 2023. “THE DISCLOSURE OF FEATURES, CHARACTERISTICS, POSSIBILITIES AND SPECIALTIES OF CLINICAL PHARMACISTS AS MEDIATOR AMONG DOCTORS AND PATIENTS FOR ENHANCEMENT PUBLIC HEALTH SECTOR IN A GLOBAL WORLD”. Experimental and Clinical Medicine Georgia, no. 4 (November):57-62. https://doi.org/10.52340/jecm.2023.04.15.
KVIZHINADZE, NATIA, NINO INTSKIRVELI, DAVID TOPURIA, NANA DUGHASHVILI, and NODAR SULASHVILI. 2023. “GSP AND ITS FEATURES IN MEDICAL AND PHARMACEUTICAL INSTITUTIONS ”. Experimental and Clinical Medicine Georgia, no. 4 (November):17-19. https://doi.org/10.52340/jecm.2023.04.03.
SULASHVILI, NODAR, NANA GORGASLIDZE, MARGARITA BEGLARYAN, LUIZA GABUNIA, NAIRA CHICHOYAN, MARINA GIORGOBIANI, IRINE ZARNADZE, and SHALVA (DAVIT) ZARNADZE. 2022. “THE SCIENTIFIC TALKS OF ESSENTIAL ISSUE, INVOCATION, PERSPECTIVES, INCLINATIONS AND FEATURES OF THE CLINICAL PHARMACISTS GLOBALLY”. Experimental and Clinical Medicine Georgia, no. 7 (October). https://doi.org/10.52340/jecm.2022.07.09.
SULASHVILI , NODAR, MARGARITA BEGLARYAN, NANA GORGASLIDZE, SEYRAN KOCHARYAN, NAIRA CHICHOYAN, LUIZA GABUNIA, NATIA KVIZHINADZE, MARINA GIORGOBIANI, IRINE ZARNADZE, and SHALVA (DAVIT) ZARNADZE. 2022. “THE SCIENTIFIC DISCUSSION OF SPECIFICITIES OF PHARMACIST OCCUPATIONAL AND HIGHER MEDICAL-PHARMACEUTICAL EDUCATIONAL MANIFESTATION OUTLOOKS IN GEORGIA”. Experimental and Clinical Medicine Georgia, no. 7 (October). https://doi.org/10.52340/jecm.2022.07.08.
GORGASLIDZE, NANA, SHAFIGA TOPCHIYEVA, MARINA GIORGOBIANI, and NODAR SULASHVILI. 2022. “THE IMPACT OF PHARMACEUTICAL MARKETING ON THE SOCIETY AND INDIVIDUAL PATIENT AND ITS SPECIFICATION OF HANDLING”. Experimental and Clinical Medicine Georgia, no. 7 (October). https://doi.org/10.52340/jecm.2022.07.07.
GORGASLIDZE, NANA, and NODAR SULASHVILI. 2022. “THE FEATURES OF THE PHARMACEUTICAL MARKET AND ITS OUTLOOKS IN GEORGIA”. Experimental and Clinical Medicine Georgia, no. 7 (October). https://doi.org/10.52340/jecm.2022.07.06.
NANA GORGASLIDZE, NODAR SULASHVILI, MARINA GIORGOBIANI, TEA ZARKUA, NANA DUGASHVILI. THE FEATURES OF INSPECTION AND MONITORING FRAMEWORK FOR PROFESSIONAL SAFETY, SANITARY, BIOECOLOGICAL, PREVENTIVE AND HYGIENIC NOVEL REQUIREMENT ISSUES OF PHARMACEUTICAL ORGANIZATIONS IN THE CONTEXT OF THE COVID-19 PANDEMIC IN GEORGIA. jecmg [Internet]. 2021 Oct. 19 [cited 2025 Jul. 12];(5-6):42-6. Available from: https://journals.4science.ge/index.php/jecm/article/view/576.
SULASHVILI, NODAR, ARTASHES AZNAURYAN, ANNA TER-MARKOSYAN, NANA GORGASLIDZE, SEYRAN KOCHARYAN, IRINE ZARNADZE, BAGRAT YENOKYAN, et al. 2021. “MODERN SCIENTIFIC DISCUSSION OF SPECIFICITES OF THE ROLE, ACHIEVEMENTS, INNOVATIONS, PROFESSIONAL AND ENHANCEMENT PROSPECTS OF PHARMACISTS IN THE CONTEXT OF THE DEVELOPMENT OF HEALTH CARE SECTOR GLOBALLY”. Experimental and Clinical Medicine Georgia, no. 5-6 (October):38-41. https://journals.4science.ge/index.php/jecm/article/view/575.
SULASHVILI, NODAR, NANA GORGASLIDZE, LUIZA GABUNIA, LEVAN RATIANI, SHORENA KHETSURIANI, VIRA KRAVCHENKO, IGOR SENIUK, MARINA GIORGOBIANI, NATIA KVIZHINADZE, and MARIKA SULASHVILI. 2024. “MANIFESTATION OF THE PARTICULARITIES OF SOME KEY ISSUE ASPECTS OF NEW IMMUNOTHERAPY CHALLENGES AND PERSPECTIVES BY CAR-T CELL THERAPY”. Experimental and Clinical Medicine Georgia, no. 4 (September):119-21. https://doi.org/10.52340/jecm.2024.04.32.
Sulashvili, Nodar, Sharon Fernando, Awad El-Hakeem, Luiza Gabunia, Nana Gorgaslidze, Margarita Beglaryan, Lali Patsia, Natia Kvizhinadze, and Marika Sulashvili. 2025. “CLOSED-LOOP CARDIOPULMONARY BYPASS SYSTEMS WITH REAL-TIME MONITORING AND PHARMACOTHERAPY STRATEGIES: INNOVATIONS, OUTCOMES, CLINICAL IMPACT AND FUTURE DIRECTIONS IN GENERAL”. Georgian Scientists 7 (2):381-419. https://doi.org/10.52340/gs.2025.07.02.36.
Sulashvili N, Jadhav RD, Beglaryan M, Gabunia L, Gorgaslidze N, Alavidze N, et al. THE SCIENTIFIC DISCUSSION OF KEY ISSUE ASPECTS OF IMMUNOPATHOGENESIS AND PHARMACOLOGICAL PROPERTIES AND PROFILES IN RELATION TO ADVERSE DRUG REACTIONS CHALLENGES, FOCUS ON MULTIDIMENSIONAL DRUG-INDUCED EOSINOPHILIA AND SYSTEMIC SYNDROME. GS [Internet]. 2025 Jul. 11 [cited 2025 Jul. 12];7(3):141-79. Available from: https://journals.4science.ge/index.php/GS/article/view/3919.
Sulashvili, Nodar, Nato Alavidze, Maka Buleishvili, Vira Kravchenko, Marika Sulashvili, Igor Seniuk, Tamar Okropiridze, Marina Giorgobiani, Lela Grigolia, and Kakhaber Robakidze. 2025. “THE MANIFESTATION OF KEY ISSUE FEATURES OF GLOBAL PERSPECTIVES ON INNOVATIVE TEACHING AND LEARNING APPROACH STRATEGIES IN HIGHER MEDICAL EDUCATION: ADVANCING STUDENT-CENTERED PRACTICES, TECHNOLOGY INTEGRATION AND COMPETENCY-BASED FRAMEWORKS ”. Scientific Journal „Spectri“ 10 (2). https://doi.org/10.52340/spectri.2024.10.01.11.
SULASHVILI, NODAR, NANA GORGASLIDZE, MARGARITA BEGLARYAN, LUIZA GABUNIA, NATIA KVIZHINADZE, TEA ZARKUA, MARINA GIORGOBIANI, NANA PEIKRISHVILI, and MARIKA SULASHVILI. 2024. “THE MANIFESTATION OF CHARACTERISTICS, OPPORTUNITIES AND CHALLENGES OF ELECTRONIC SYSTEMS AND DIGITAL INTELLIGENCE USING IN PHARMACEUTICAL SERVICES”. Experimental and Clinical Medicine Georgia, no. 4 (September):122-25. https://doi.org/10.52340/jecm.2024.04.33.
Sulashvili N, Davitashvili M, Gorgaslidze N, Gabunia L, Beglaryan M, Alavidze N, et al. THE SCIENTIFIC DISCUSSION OF SOME ISSUES OF FEATURES AND CHALLENGES OF USING OF CAR-T CELLS IN IMMUNOTHERAPY. GS [Internet]. 2024 Nov. 26 [cited 2025 Jul. 12];6(4):263-90. Available from: https://journals.4science.ge/index.php/GS/article/view/3214.
Sulashvili, Nodar, Udgam Yaduvanshi, Mohini Yadav, Luiza Gabunia, Ketevan Ghambashidze, Nana Gorgaslidze, Margarita Beglaryan, et al. 2025. “THE SCIENTIFIC DISCOURSE OF FEATURES OF CLINICAL USE AND PHARMACOLOGY OF VASOCONSTRICTORS AND THEIR IMPACT ON CARDIAC FUNCTION”. Junior Researchers 3 (1):28-68. https://doi.org/10.52340/jr.2025.03.01.02.
Sulashvili N, Nimangre RR. MANIFESTATION OF SOME ASPECTS OF CARDIOVASCULAR DISEASES, IMPLICATIONS, PHARMACOTHERAPEUTIC STRATEGIES, EFFECTS, IMPACTS AND POTENTIAL HAZARDS IN GENERAL. JR [Internet]. 2025 Feb. 7 [cited 2025 Jul. 12];3(1):1-27. Available from: https://journals.4science.ge/index.php/jr/article/view/3393.
Goodyear-Smith F, Bazemore A, Coffman M, Fortier R, Howe A, Kidd M, et al. Research and the future of primary care. Lancet. 2018 Aug 4;392(10144):432-3.
Willink A, Isenberg SR, Cherlin EJ, Bradley EH. Training family physicians and general internists to provide palliative care: a review of the literature. Palliat Med. 2016 Jun;30(6):533-9.
Ghorob A, Bodenheimer T. Sharing the care to improve access to primary care. N Engl J Med. 2012 May 24;366(21):1955-7.
Dixon-Woods M, Amalberti R, Goodman S, Bergman B, Glasziou P. Problems and promises of innovation: why healthcare needs to rethink its love/hate relationship with the new. BMJ Qual Saf. 2011 Dec;20 Suppl 1:i47-51.
Zulman DM, Chee CP, Wagner TH, Yoon J, Cohen DM, Holmes TH, et al. Multimorbidity and healthcare utilisation among high-cost patients in the US Veterans Affairs Health Care System. BMJ Open. 2015 Apr 15;5(4):e007771.
Copyright (c) 2025 Georgian Scientists

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

